A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication Nested in the Antiretroviral Pregnancy Registry
Phase of Trial: Phase IV
Latest Information Update: 02 Apr 2018
Price : $35 *
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- 22 Feb 2017 Status changed from active, no longer recruiting to completed.
- 08 Dec 2016 Planned End Date changed from 1 Nov 2016 to 1 Jan 2017.
- 08 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jan 2017.